Saratoga Research & Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.89M |
| 2 |
Amgen
AMGN
|
+$258K |
| 3 |
Visa
V
|
+$45.6K |
| 4 |
Diageo
DEO
|
+$14.3K |
| 5 |
Paychex
PAYX
|
+$12.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.81M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$3.79M |
| 3 |
Oracle
ORCL
|
+$3.72M |
| 4 |
Cisco
CSCO
|
+$3.17M |
| 5 |
Walmart Inc
WMT
|
+$2.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.25% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Staples | 13.23% |
| 4 | Industrials | 12.02% |
| 5 | Consumer Discretionary | 8.26% |
Similar funds
Saratoga Research & Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Saratoga Research & Investment Management held 45 positions worth $1.26B, down 15% from $1.48B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Saratoga Research & Investment Management withdrew a net $53.6M in Q4 2018, closing 2 positions and reducing 28 holdings. Its most notable exit was Tapestry, an estimated $282K position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Saratoga Research & Investment Management added an estimated $3.89M to Apple.
- Saratoga Research & Investment Management added most to Apple in Q4 2018, an estimated $3.89M increase.
- Saratoga Research & Investment Management's biggest Q4 2018 reduction was Microsoft, cutting an estimated $5.81M.
- Saratoga Research & Investment Management fully exited Tapestry in Q4 2018, selling an estimated $282K.
- Saratoga Research & Investment Management's ten largest holdings make up 54% of its $1.26B portfolio in Q4 2018.
- Saratoga Research & Investment Management opened 0 new positions and closed 2 in Q4 2018.
- Saratoga Research & Investment Management's portfolio value fell 15% quarter-over-quarter to $1.26B.
Based on Saratoga Research & Investment Management's 13F filing for Q4 2018, filed 15 Jan 2019.